Guerbet 
Welcome,         Profile    Billing    Logout  
 1 Product   4 Diseases  1 Product   20 Trials   567 News 
29 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dotarem (gadoterate meglumine) / Guerbet
2009-009426-81: Contrast-enhanced Imaging of the Abdomen: Gadovist® vs. Dotarem® – Intraindividual comparison of 0.1mmol/kg bw gadoterate meglumine with 0.1mmol/kg bw gadobutrol for dynamic abdominal imaging in patients with suspected focal liver or renal lesions

Ongoing
4
100
Europe
V08CA09, V08CA02, Solution for injection, Gadovist 1.0 mmol/ml, Injektionslösung, Dotarem 0,5mmol/ml, Injektionslösung
University Heidelberg
patients with suspected focal liver or renal lesions
 
 
2013-002409-75: Comparison of 2 contrast agents for Magnetic Resonance Imaging in patients with liver cancer Vergleich von 2 Kontrastmitteln für die MRT der Leber bei Patienten mit Leberkrebs

Ongoing
4
30
Europe
Primovist, Dotarem, Solution for injection, Primovist, Dotarem
Charite, Bayer AG
Patients with liver cirrhosis and diagnosis of hepatocellular carcinoma based on noninvasive HCC diagnostic (EASL) criteria Patienten mit Leberzirrhose und Diagnose eines hepatozellulären Karzinoms auf der Basis der nicht-invasiven EASL-Kriterien., Patients with liver cirrhoses who suffer, in addition, from liver cancer. Patienten mit Leberzirrhose und Leberkrebs., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
 
 
2010-021526-36: Comparison of the performance of three contrast agents (Gadovist, Dotarem and Multihance) in magnetic resonance imaging (MRI) in volunteers and patients with narrowing or constriction of the inner surface of the carotid artery

Ongoing
4
20
Europe
Gadovist, Dotarem, Multihance, Gadovist, Dotarem, Multihance
Klinikum der Universität München, Bayer Schering Pharma AG
Supraaortic vessel disease; suspicion or proven carotid artery stenosis / stenoses
 
 
2009-014857-34: Intra-individual, randomized multicentric comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem in patients with Multiple Sclerosis at 3T

Ongoing
4
50
Europe
V08CA09, V08CA02, Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml, Injektionslösung, Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml, Injektionslösung
Universitätsklinikum Erlangen
Patients with clinically definite MS or a clinically isolated episode of CNS involvement and disease dissemination in space, according to the McDonald’s criteria
 
 
2017-001300-30: Comparison of deep, intermediate and superficial regional anesthetic block for carotid surgery concerning nerval paresis, lung function and tissue distribution Vergleich der tiefen, mittleren und oberflächlichen Regionalanästhesie zur Karotischirurgie hinsichtlich Nervenlähmung, Lungenfunktion und Gewebeverteilung

Ongoing
4
45
Europe
Dotarem, Injection, Dotarem
UK für Anästhesieologie, Gemeinn. Sbg. Landeskliniken BetriebsgesmbH, UK für Anästhesieologie, Gemeinn. Sbg. Landeskliniken BetriebsgesmbH
deep, intermediate or superficial cervical plexus block for carotid endarterectomy tiefer, mittlerer oder oberflächlicher zervikaler Plexusblock für Karotisendarterektomie, regional anesthesia technique for carotid surgery regionalanästhesiologische Technik für Karotischirurgie, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
ChiCTR1900022694: Post-Marketing Study for Evaluation of Gadoterate Meglumine Immediate Adverse Reactions within One Hour in Children Younger than Two Years Old

Recruiting
4
330
 
Gd-DOTA
Tianjin Children Hospital; Tianjin Children Hospital, Heng Rui Pharmaceuticals
Acute Adverse Reaction
 
 
2019-004730-42: Long-term impact of GBCAs on motor and cognitive function following repeated Contrast-Enhanced MRI—ODYSSEY. Langetermijnimpact van GBCA’s op de motorische en cognitieve functie na herhaalde contrastversterkte MRI-ODYSSEY-onderzoek.

Not yet recruiting
4
2076
Europe
MultiHance, DOTAREM® (gadoterate meglumine) Injection for intravenous use, ProHance, Gadovist, Primovist, [NA], Solution for injection, Solution for infusion, Solution for injection in pre-filled syringe, Solution for infusion in pre-filled syringe, MultiHance, DOTAREM® (gadoterate meglumine) Injection for intravenous use, ProHance (gadoteridol injection), Gadovist, Primovist
IQVIA RDS FRANCE SAS, Bayer AG, Bracco Imaging S.p.A., GE Healthcare Pharma LLC, Guerbet
Long term potential effect of repeated exposure to either a linear or a macrocyclic gadolinium-based contrast agent (GBCA) on change from baseline to Year 5 in motor and cognitive function among neurologically normal adults in comparison to a matched non-GBCA–exposed control group effects regarding Mogelijke langetermijneffect van herhaalde blootstelling aan een lineair of een macrocyclisch gadoliniumgebaseerd contrastmiddel (GBCA) op de verandering van baseline tot jaar 5 in motorische en cognitieve functie bij neurologisch normale volwassenen in vergelijking met een gematchte controlegroep zonder blootstelling aan GBCA., Prospective evaluation of potential effects of repeated gadolinium-based contrast agent administrations Prospectieve beoordeling van mogelijke effecten van herhaalde toediening van hetzelfde gadolinium-gebaseerde contrastmiddel (GBCA), Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
 
 
ChiCTR2000040696: A multicenter prospective observational study on the safety of meglumine gadolinate in the population of Southwest China

Not yet recruiting
4
3000
 
Gadoterate meglumine
Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, Sichuan Red Cross Foundation
Safty of Gadoterate meglumine
 
 
NCT03730051: Dotarem vs Gadobutrol Contrast for Breast MRI

Recruiting
4
258
US
Gadoterate meglumine, Dotarem, Gadobutrol, Gadavist
University of Massachusetts, Worcester, Guerbet
Breast Diseases
07/25
03/26
ODYSSEY, NCT04373564: Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Recruiting
4
2076
Europe, Canada, US, RoW
Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain, Gadolinium Measurements, Gadoxetate disodium, Eovist, Primovist, BAY86-4873, Gadobenate dimeglumine, MultiHance, Gadodiamide, Omniscan, Gadoterate meglumine, Dotarem, Magnescope, Gadobutrol, BAY86-4875, Gadavist, Gadovist, Gadoteridol, ProHance
Guerbet, Bayer AG (Sponsor), Bracco (Sponsor), GEHC (Sponsor)
Motor Function, Cognitive Function, Contrast Media
12/28
12/28
2007-004222-24: Intra-individual, randomized comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem when imaging the pelvis in patients with spondylarthritides, evaluated in a blinded read

Ongoing
3
60
Europe
Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml Injektionslösung, Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml Injektionslösung
Dekan des FB Medizin der Johann-Wolfgang Goethe-Universität
Polyarthritis
 
 
2009-013432-20: Intra-individual, randomized comparison of the MRI contrast agents gadobutrol versus gadoterate meglumine in breast MR imaging

Ongoing
3
52
Europe
V08C A09, V08CA02, Gadovist 1.0 mmol/ml, Dotarem 0.5 mmol/ml, Gadovist 1.0 mmol/ml, Dotarem 0.5 mmol/ml
Charité Campus Mitte
Breast tumor
 
 
2009-012318-33: EVALUATION DE LA PRISE DE CONTRASTE APRES INJECTION DE VASOVIST DANS LES LESIONS INFLAMMATOIRES DE SCLEROSE EN PLAQUES

Ongoing
3
30
Europe
Vasovist, Dotarem, Vasovist, Dotarem
Hôpitaux Universitaires de Strasbourg
Patients présentant une sclérose en plaques avec des lésions inflammatoires aigues rehaussées sur une première IRM réalisée avec un chélate de gadolinium standard.
 
 
2022-002720-12: A study looking at the performance of Elucirem® (gadopiclenol) when used for advanced radiological examinations of brain gliomas.

Not yet recruiting
3
138
Europe
Elucirem, Dotarem 0.5 mol/l, solution for injection in vials, P03277/G03277, G449.06, Solution for injection, Elucirem, Dotarem
Guerbet, Guerbet
Naive or recurrent primary glial tumor, Patients with glial tumor scheduled to undergo Magnetic Resonance Imaging (MRI), Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
 
 
GDX-44-016, NCT06057168 / 2022-002720-12: Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas

Completed
3
138
Europe
Elucirem, gadopiclenol, Dotarem, gadoterate meglumine, gadoteric acid
Guerbet, Guerbet
Brain Tumor, Primary, Brain Tumor, Recurrent
11/24
11/24
Quanti CNS, NCT05915702: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

Completed
3
303
Europe, Canada, Japan, US, RoW
Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine, Gadoteric acid, Gadoteridol
Bayer
Contrast Enhancement in Magnetic Resonance Imaging, Central Nervous System Pathology
05/24
12/24
Quanti OBR, NCT05915728: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Completed
3
404
Europe, Canada, Japan, US, RoW
Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine, Gadoteric acid, Gadoteridol
Bayer
Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology
05/24
06/24
2013-000630-35: Pilot study on use of Sulphur hexafluoride Microbubbles (SonoVue®) as a Magnetic Resonance Imaging contrast agent in the imaging of brain tumours.

Ongoing
2
60
Europe
SonoVue®, Dotarem, Gadovist, SonoVue, Dotarem, Gadovist, SonoVue, Dotarem, Gadovist
Alder Hey Children\'s NHS Foundation Trust
Patients undergoing pre-operative/follow up MRI investigation for a known enhancing brain tumour
 
 
NCT05417776: Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Recruiting
2
30
US
[68Ga]CBP8, Dotarem, gadoterate meglumine
Massachusetts General Hospital, Boehringer Ingelheim
Interstitial Lung Disease
04/26
04/26
NCT06532071: Advanced Imaging for Pulmonary Fibrosis

Recruiting
2
60
US
[68Ga]CBP8, Gadoterate Meglumine, Dotarem
Peter Caravan
Pulmonary Fibrosis
12/28
12/28
NCT04341129: Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Completed
1
50
US
Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine), Abbreviated MRI, Abbreviated MRI with Dotarem, Dotarem
University of Chicago, Guerbet
Breast Neoplasms, Breast Diseases, Breast Fibroadenoma, Breast Cancer
06/23
06/23
NCT05453539: Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease

Recruiting
1
18
Europe
DSPE-DOTA-Gd Liposomal Injection, ADx-001
Alzeca Biosciences, Inc., pharmtrace klinische Entwicklung GmbH
Alzheimer Disease
01/25
01/25
NCT06704932: A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee

Recruiting
1
32
Europe
SAR446959, Placebo
Sanofi
Osteoarthritis
12/25
12/25
FUS-AD, NCT06600880: Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Not yet recruiting
1
6
US
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents, Positron Emission Tomography (PET), Amyvid, 18F-Florbetapir, MK-6240, Dotarem, Blood draw, UR5e, Urine test
Columbia University
Alzheimer Disease, Early Onset
07/27
12/27
NCT01514617: Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Active, not recruiting
N/A
100
Europe
Diffusion -and perfusion weighted MRI including iv contrast agent injection, Dotarem
Universitaire Ziekenhuizen KU Leuven
Leiomyomas
12/25
12/25
NCT03937921: Dotarem Evaluation for Myocardial Perfusion CMR

Completed
N/A
90
US
Gadavist 15Ml Solution for Injection
Medical University of South Carolina, Guerbet
Myocardial Perfusion Imaging, Magnetic Resonance Imaging
10/24
10/24
NCT03337594: Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Completed
N/A
57
US
Pre-operative MRI with Dotarem, gadoterate meglumine, Pre-operative MRI with MultiHance, gadobenate dimeglumine, Surgery
Donna Roberts, National Institute of Standards and Technology
Gadolinium, MultiHance, Dotarem, Magnetic Resonance Imaging, Gadolinium Retention
08/24
08/24
NCT05937776: Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Recruiting
N/A
20
US
Fludeoxyglucose F-18, ¹⁸FDG, 2-Deoxy-2-(18F)Fluoro-D-Glucose, 2-F18-Fluoro-2-deoxy-D-glucose, Fludeoxyglucose (18F), 105851-17-0, 2-F18-Fluoro-2-deoxyglucose, FDG, fludeoxyglucose F 18, Fluorine-18, Fludeoxyglucose F18, 2-Fluoro-2-deoxy-D-Glucose, Gadoterate Meglumine, 92943-93-6, DOTAREM, Gd-DOTA, Contrast-enhanced Magnetic Resonance Imaging, CONTRAST ENHANCED MRI, Contrast-enhanced MRI, MRI With Contrast, Positron Emission Tomography, Medical Imaging, PET, PET Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
OHSU Knight Cancer Institute, Oregon Health and Science University
Glioma
12/25
12/25
NCT06754956: Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs

Recruiting
N/A
100
RoW
The patient will receive two intravenous injections of the same gadoterate meglumine contrast agent.
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
High Resolution Vessel Wall Imaging, Intracranial Atherosclerotic Stenosis, ICAS, Arteriosclerosis
09/27
12/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dotarem (gadoterate meglumine) / Guerbet
2009-009426-81: Contrast-enhanced Imaging of the Abdomen: Gadovist® vs. Dotarem® – Intraindividual comparison of 0.1mmol/kg bw gadoterate meglumine with 0.1mmol/kg bw gadobutrol for dynamic abdominal imaging in patients with suspected focal liver or renal lesions

Ongoing
4
100
Europe
V08CA09, V08CA02, Solution for injection, Gadovist 1.0 mmol/ml, Injektionslösung, Dotarem 0,5mmol/ml, Injektionslösung
University Heidelberg
patients with suspected focal liver or renal lesions
 
 
2013-002409-75: Comparison of 2 contrast agents for Magnetic Resonance Imaging in patients with liver cancer Vergleich von 2 Kontrastmitteln für die MRT der Leber bei Patienten mit Leberkrebs

Ongoing
4
30
Europe
Primovist, Dotarem, Solution for injection, Primovist, Dotarem
Charite, Bayer AG
Patients with liver cirrhosis and diagnosis of hepatocellular carcinoma based on noninvasive HCC diagnostic (EASL) criteria Patienten mit Leberzirrhose und Diagnose eines hepatozellulären Karzinoms auf der Basis der nicht-invasiven EASL-Kriterien., Patients with liver cirrhoses who suffer, in addition, from liver cancer. Patienten mit Leberzirrhose und Leberkrebs., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
 
 
2010-021526-36: Comparison of the performance of three contrast agents (Gadovist, Dotarem and Multihance) in magnetic resonance imaging (MRI) in volunteers and patients with narrowing or constriction of the inner surface of the carotid artery

Ongoing
4
20
Europe
Gadovist, Dotarem, Multihance, Gadovist, Dotarem, Multihance
Klinikum der Universität München, Bayer Schering Pharma AG
Supraaortic vessel disease; suspicion or proven carotid artery stenosis / stenoses
 
 
2009-014857-34: Intra-individual, randomized multicentric comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem in patients with Multiple Sclerosis at 3T

Ongoing
4
50
Europe
V08CA09, V08CA02, Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml, Injektionslösung, Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml, Injektionslösung
Universitätsklinikum Erlangen
Patients with clinically definite MS or a clinically isolated episode of CNS involvement and disease dissemination in space, according to the McDonald’s criteria
 
 
2017-001300-30: Comparison of deep, intermediate and superficial regional anesthetic block for carotid surgery concerning nerval paresis, lung function and tissue distribution Vergleich der tiefen, mittleren und oberflächlichen Regionalanästhesie zur Karotischirurgie hinsichtlich Nervenlähmung, Lungenfunktion und Gewebeverteilung

Ongoing
4
45
Europe
Dotarem, Injection, Dotarem
UK für Anästhesieologie, Gemeinn. Sbg. Landeskliniken BetriebsgesmbH, UK für Anästhesieologie, Gemeinn. Sbg. Landeskliniken BetriebsgesmbH
deep, intermediate or superficial cervical plexus block for carotid endarterectomy tiefer, mittlerer oder oberflächlicher zervikaler Plexusblock für Karotisendarterektomie, regional anesthesia technique for carotid surgery regionalanästhesiologische Technik für Karotischirurgie, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
ChiCTR1900022694: Post-Marketing Study for Evaluation of Gadoterate Meglumine Immediate Adverse Reactions within One Hour in Children Younger than Two Years Old

Recruiting
4
330
 
Gd-DOTA
Tianjin Children Hospital; Tianjin Children Hospital, Heng Rui Pharmaceuticals
Acute Adverse Reaction
 
 
2019-004730-42: Long-term impact of GBCAs on motor and cognitive function following repeated Contrast-Enhanced MRI—ODYSSEY. Langetermijnimpact van GBCA’s op de motorische en cognitieve functie na herhaalde contrastversterkte MRI-ODYSSEY-onderzoek.

Not yet recruiting
4
2076
Europe
MultiHance, DOTAREM® (gadoterate meglumine) Injection for intravenous use, ProHance, Gadovist, Primovist, [NA], Solution for injection, Solution for infusion, Solution for injection in pre-filled syringe, Solution for infusion in pre-filled syringe, MultiHance, DOTAREM® (gadoterate meglumine) Injection for intravenous use, ProHance (gadoteridol injection), Gadovist, Primovist
IQVIA RDS FRANCE SAS, Bayer AG, Bracco Imaging S.p.A., GE Healthcare Pharma LLC, Guerbet
Long term potential effect of repeated exposure to either a linear or a macrocyclic gadolinium-based contrast agent (GBCA) on change from baseline to Year 5 in motor and cognitive function among neurologically normal adults in comparison to a matched non-GBCA–exposed control group effects regarding Mogelijke langetermijneffect van herhaalde blootstelling aan een lineair of een macrocyclisch gadoliniumgebaseerd contrastmiddel (GBCA) op de verandering van baseline tot jaar 5 in motorische en cognitieve functie bij neurologisch normale volwassenen in vergelijking met een gematchte controlegroep zonder blootstelling aan GBCA., Prospective evaluation of potential effects of repeated gadolinium-based contrast agent administrations Prospectieve beoordeling van mogelijke effecten van herhaalde toediening van hetzelfde gadolinium-gebaseerde contrastmiddel (GBCA), Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
 
 
ChiCTR2000040696: A multicenter prospective observational study on the safety of meglumine gadolinate in the population of Southwest China

Not yet recruiting
4
3000
 
Gadoterate meglumine
Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, Sichuan Red Cross Foundation
Safty of Gadoterate meglumine
 
 
NCT03730051: Dotarem vs Gadobutrol Contrast for Breast MRI

Recruiting
4
258
US
Gadoterate meglumine, Dotarem, Gadobutrol, Gadavist
University of Massachusetts, Worcester, Guerbet
Breast Diseases
07/25
03/26
ODYSSEY, NCT04373564: Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Recruiting
4
2076
Europe, Canada, US, RoW
Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain, Gadolinium Measurements, Gadoxetate disodium, Eovist, Primovist, BAY86-4873, Gadobenate dimeglumine, MultiHance, Gadodiamide, Omniscan, Gadoterate meglumine, Dotarem, Magnescope, Gadobutrol, BAY86-4875, Gadavist, Gadovist, Gadoteridol, ProHance
Guerbet, Bayer AG (Sponsor), Bracco (Sponsor), GEHC (Sponsor)
Motor Function, Cognitive Function, Contrast Media
12/28
12/28
2007-004222-24: Intra-individual, randomized comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem when imaging the pelvis in patients with spondylarthritides, evaluated in a blinded read

Ongoing
3
60
Europe
Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml Injektionslösung, Gadovist 1.0 mmol/ml Injektionslösung, Dotarem 0,5mmol/ml Injektionslösung
Dekan des FB Medizin der Johann-Wolfgang Goethe-Universität
Polyarthritis
 
 
2009-013432-20: Intra-individual, randomized comparison of the MRI contrast agents gadobutrol versus gadoterate meglumine in breast MR imaging

Ongoing
3
52
Europe
V08C A09, V08CA02, Gadovist 1.0 mmol/ml, Dotarem 0.5 mmol/ml, Gadovist 1.0 mmol/ml, Dotarem 0.5 mmol/ml
Charité Campus Mitte
Breast tumor
 
 
2009-012318-33: EVALUATION DE LA PRISE DE CONTRASTE APRES INJECTION DE VASOVIST DANS LES LESIONS INFLAMMATOIRES DE SCLEROSE EN PLAQUES

Ongoing
3
30
Europe
Vasovist, Dotarem, Vasovist, Dotarem
Hôpitaux Universitaires de Strasbourg
Patients présentant une sclérose en plaques avec des lésions inflammatoires aigues rehaussées sur une première IRM réalisée avec un chélate de gadolinium standard.
 
 
2022-002720-12: A study looking at the performance of Elucirem® (gadopiclenol) when used for advanced radiological examinations of brain gliomas.

Not yet recruiting
3
138
Europe
Elucirem, Dotarem 0.5 mol/l, solution for injection in vials, P03277/G03277, G449.06, Solution for injection, Elucirem, Dotarem
Guerbet, Guerbet
Naive or recurrent primary glial tumor, Patients with glial tumor scheduled to undergo Magnetic Resonance Imaging (MRI), Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
 
 
GDX-44-016, NCT06057168 / 2022-002720-12: Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas

Completed
3
138
Europe
Elucirem, gadopiclenol, Dotarem, gadoterate meglumine, gadoteric acid
Guerbet, Guerbet
Brain Tumor, Primary, Brain Tumor, Recurrent
11/24
11/24
Quanti CNS, NCT05915702: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

Completed
3
303
Europe, Canada, Japan, US, RoW
Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine, Gadoteric acid, Gadoteridol
Bayer
Contrast Enhancement in Magnetic Resonance Imaging, Central Nervous System Pathology
05/24
12/24
Quanti OBR, NCT05915728: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Completed
3
404
Europe, Canada, Japan, US, RoW
Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine, Gadoteric acid, Gadoteridol
Bayer
Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology
05/24
06/24
2013-000630-35: Pilot study on use of Sulphur hexafluoride Microbubbles (SonoVue®) as a Magnetic Resonance Imaging contrast agent in the imaging of brain tumours.

Ongoing
2
60
Europe
SonoVue®, Dotarem, Gadovist, SonoVue, Dotarem, Gadovist, SonoVue, Dotarem, Gadovist
Alder Hey Children\'s NHS Foundation Trust
Patients undergoing pre-operative/follow up MRI investigation for a known enhancing brain tumour
 
 
NCT05417776: Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Recruiting
2
30
US
[68Ga]CBP8, Dotarem, gadoterate meglumine
Massachusetts General Hospital, Boehringer Ingelheim
Interstitial Lung Disease
04/26
04/26
NCT06532071: Advanced Imaging for Pulmonary Fibrosis

Recruiting
2
60
US
[68Ga]CBP8, Gadoterate Meglumine, Dotarem
Peter Caravan
Pulmonary Fibrosis
12/28
12/28
NCT04341129: Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Completed
1
50
US
Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine), Abbreviated MRI, Abbreviated MRI with Dotarem, Dotarem
University of Chicago, Guerbet
Breast Neoplasms, Breast Diseases, Breast Fibroadenoma, Breast Cancer
06/23
06/23
NCT05453539: Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease

Recruiting
1
18
Europe
DSPE-DOTA-Gd Liposomal Injection, ADx-001
Alzeca Biosciences, Inc., pharmtrace klinische Entwicklung GmbH
Alzheimer Disease
01/25
01/25
NCT06704932: A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee

Recruiting
1
32
Europe
SAR446959, Placebo
Sanofi
Osteoarthritis
12/25
12/25
FUS-AD, NCT06600880: Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Not yet recruiting
1
6
US
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents, Positron Emission Tomography (PET), Amyvid, 18F-Florbetapir, MK-6240, Dotarem, Blood draw, UR5e, Urine test
Columbia University
Alzheimer Disease, Early Onset
07/27
12/27
NCT01514617: Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Active, not recruiting
N/A
100
Europe
Diffusion -and perfusion weighted MRI including iv contrast agent injection, Dotarem
Universitaire Ziekenhuizen KU Leuven
Leiomyomas
12/25
12/25
NCT03937921: Dotarem Evaluation for Myocardial Perfusion CMR

Completed
N/A
90
US
Gadavist 15Ml Solution for Injection
Medical University of South Carolina, Guerbet
Myocardial Perfusion Imaging, Magnetic Resonance Imaging
10/24
10/24
NCT03337594: Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Completed
N/A
57
US
Pre-operative MRI with Dotarem, gadoterate meglumine, Pre-operative MRI with MultiHance, gadobenate dimeglumine, Surgery
Donna Roberts, National Institute of Standards and Technology
Gadolinium, MultiHance, Dotarem, Magnetic Resonance Imaging, Gadolinium Retention
08/24
08/24
NCT05937776: Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Recruiting
N/A
20
US
Fludeoxyglucose F-18, ¹⁸FDG, 2-Deoxy-2-(18F)Fluoro-D-Glucose, 2-F18-Fluoro-2-deoxy-D-glucose, Fludeoxyglucose (18F), 105851-17-0, 2-F18-Fluoro-2-deoxyglucose, FDG, fludeoxyglucose F 18, Fluorine-18, Fludeoxyglucose F18, 2-Fluoro-2-deoxy-D-Glucose, Gadoterate Meglumine, 92943-93-6, DOTAREM, Gd-DOTA, Contrast-enhanced Magnetic Resonance Imaging, CONTRAST ENHANCED MRI, Contrast-enhanced MRI, MRI With Contrast, Positron Emission Tomography, Medical Imaging, PET, PET Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
OHSU Knight Cancer Institute, Oregon Health and Science University
Glioma
12/25
12/25
NCT06754956: Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs

Recruiting
N/A
100
RoW
The patient will receive two intravenous injections of the same gadoterate meglumine contrast agent.
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
High Resolution Vessel Wall Imaging, Intracranial Atherosclerotic Stenosis, ICAS, Arteriosclerosis
09/27
12/27

Download Options